What is already known:
In a prospective clinical study, combination of flucloxacillin and vancomycin increased acute kidney injury as demonstrated by elevated serum creatinine levels.
Imipenem-cilastatin has decreased vancomycin-associated nephrotoxicity in pre-clinical studies.